165 related articles for article (PubMed ID: 33574675)
1. Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients.
Huo X; Zhou X; Peng P; Yu M; Zhang Y; Yang J; Cao D; Sun H; Shen K
Onco Targets Ther; 2021; 14():809-822. PubMed ID: 33574675
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
3. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Gao Y; Li Y; Niu X; Wu Y; Guan X; Hong Y; Chen H; Song B
Biomed Res Int; 2020; 2020():5323614. PubMed ID: 32462000
[TBL] [Abstract][Full Text] [Related]
5. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
8. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Qu X; Shi Z; Guo J; Guo C; Qiu J; Hua K
Cancer Med; 2021 Oct; 10(19):6881-6896. PubMed ID: 34498424
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
[TBL] [Abstract][Full Text] [Related]
11. Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
Cao Y; Lu X; Li Y; Fu J; Li H; Li X; Chang Z; Liu S
PeerJ; 2020; 8():e10320. PubMed ID: 33344071
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Chen Y; Lin H; Pi YN; Chen XX; Zhou H; Tian Y; Zhao WD; Xia BR
Front Oncol; 2021; 11():616530. PubMed ID: 33842318
[TBL] [Abstract][Full Text] [Related]
13. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
14. Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.
Qiao GJ; Chen L; Wu JC; Li ZR
PeerJ; 2019; 7():e6548. PubMed ID: 30918751
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma.
Zhu S; Lin F; Chen Z; Jiang X; Zhang J; Yang Q; Chen Y; Wang J
Front Genet; 2020; 11():563882. PubMed ID: 33101383
[TBL] [Abstract][Full Text] [Related]
16. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.
Wang J; Chen X; Tian Y; Zhu G; Qin Y; Chen X; Pi L; Wei M; Liu G; Li Z; Chen C; Lv Y; Cai G
Aging (Albany NY); 2020 Jan; 12(1):767-783. PubMed ID: 31927533
[TBL] [Abstract][Full Text] [Related]
17. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
Yu J; Liang LL; Liu J; Liu TT; Li J; Xiu L; Zeng J; Wang TT; Wang D; Liang LJ; Xie DW; Chen DX; An JS; Wu LY
Front Genet; 2021; 12():733715. PubMed ID: 34630524
[No Abstract] [Full Text] [Related]
19. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer.
Sun H; Cao D; Ma X; Yang J; Peng P; Yu M; Zhou H; Zhang Y; Li L; Huo X; Shen K
Front Genet; 2019; 10():839. PubMed ID: 31572446
[No Abstract] [Full Text] [Related]
[Next] [New Search]